Custom software and MedTech integration services for enterprises
Dash Technologies is a professional services firm building custom software for healthcare, MIoT, and enterprise integration. The stack reveals a Java-Spring-Oracle backbone with modern frontend tooling (React, Redux) and cloud deployment on Azure—a typical enterprise integration posture. Active projects span identity management, microservices refactoring, and CI/CD automation, while pain points cluster around requirement clarity and legacy modernization, suggesting they're helping clients unwind tangled systems rather than greenfield work.
Dash Technologies, founded in 2010 and based in Dublin, Ohio, is a custom software development and professional services firm with 201–500 employees. They specialize in Medical Internet of Things (MIoT), connected device integration, and enterprise system modernization for mid-market and large enterprises. The company operates across custom development, product engineering, cloud services, and quality assurance, with recent hiring concentrated in engineering and sales roles. They hold ISO 9001 certification and serve healthcare, industrial IoT, and digital transformation initiatives.
Core stack: Java, Spring Boot, Oracle, and Azure cloud. Frontend: React with Redux Toolkit. DevOps: Jira, Confluence, Maven/Gradle. Enterprise tools: SAP Fieldglass, Workday, LinkedIn Sales Navigator. Adopting Bullhorn for recruitment.
Identity management architecture, enterprise Java microservices development, CI/CD pipeline implementation, Oracle database optimization, and building internal dashboards and reusable templates.
Dash Technologies Inc.'s technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.